New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 2004; 46: 1050-1059Mittal B, Hurwitz S, Rennke H et al. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J ...
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis. Kidney Int 2022; 101:403. Rovin BH, Teng YKO, Ginzler EM, et al. Efficacy and safety of ...
In mesangial proliferative lupus nephritis (class II) extrarenal manifestations determine the immunosuppressive treatment. However, in class III and IV (focal or diffuse proliferative manifestation) cyclophosphamide or possibly mycophenolate mofetil (MMF) as an alternative is necessary. In membranous lupus ...
Nephritis in systemic lupus erythematosus is one of the manifestations of organ damage in this autoimmune disease. Class IV is the most ominous among the classes of nephritides and there are conflicting reports on whether class IV-G lupus nephritis differs from class IV-S as defined by the Int...
The two major clinical manifestations in the Class IV patients were an acute nephritis syndrome in 83% and renal failure in 61%. The nephrotic syndrome was seen in 62% of Class V (membranous GN) cases. There was 100% survival in Classes II (mesangial GN) and V (membranous GN), and ...
Successful treatment of class V+IV lupus nephritis with multitarget therapy Journal of the American Society of Nephrology : JASNSuccessful treatment of class V IV lupus nephritis with multitarget therapy. H Bao,ZH Liu,HL Xie,WX... H Bao,ZH Liu,HL Xie,... - 《Journal of the American Soci...
Lupus nephritis class I - minimum mesangial glomerulonephritis Lupus nephritis class II - mesangial proliferative glomerulonephritis Lupus nephritis class III - focal proliferative glomerulonephritis Lupus nephritis class IV - diffuse proliferative glomerulonephritis ...
et al. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis. Clin. Nephrol. 76, 136–143 (2011). Article CAS PubMed Google Scholar Bao, H. et al. Successful treatment of class V+IV lupus nephritis with multitarget therapy...
Lupus nephritis (LN) develops in almost 60% of patients with systemic lupus erythematosus. In its most severe proliferative forms, LN often leads to end-stage renal failure. Therapeutic regimens in severe lupus nephropathies, especially class IV according to WHO, are based on glucocorticosteroids ...
The most common type of renal pathology was class IV lupus nephritis. In follow up, 29.2% and 25% of patients had chronic renal failure and hypertension respectively. The most significantly associated factor was the presence of hypertension at the time of presentation (p=0.03). Five year renal...